In vitro quantitative determination of phospholipid adducts of chloroform intermediates in hepatic and renal microsomes from different rodent strains

Environmental Toxicology and Pharmacology

Volumn 2, Issue 2-3, 1996, Pages 233-242

  Gemma, Simonetta ^a   Ade, Paola ^a   Sbraccia, Maria ^a   Testai, Emanuela ^a   Vittozzi, Luciano ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

B6C3F1 mouse; Chloroform; In vitro metabolism; Kidney; Liver; Osborne Mendel rat; Phospholipid adduct; Sprague Dawley rat

Indexed keywords

CHLOROFORM; PHOSPHOLIPID;

CONFERENCE PAPER; IN VITRO STUDY; KIDNEY MICROSOME; LIVER MICROSOME; MALE; METABOLIC ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; XENOBIOTIC METABOLISM;

EID: 0030588192     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(96)00060-9     Document Type: Conference Paper

References (40)

1. Ade, P., C. Guastadisegni, E. Testai and L. Vittozzi, 1994, Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. J. Biochem. Toxicol. 9, 289.
2. Ahmadizadeh, M., C.H. Kuo and J.B. Hook, 1981, Nephrotoxicity and hepatotoxicily of chloroform in mice: effect of deuterium substitution, J. Toxicol. Environ. Health 8, 105.
3. Branchflower, R.V. and L.R. Pohl, 1981. Investigation of the mechanism of the potentiation of chloroform-induced hepatotoxicity and nephrotoxicity by methyl n-butyl ketone, Toxicol. Appl. Pharmacol. 61, 407.
4. Clemens, T.L., R.N. Hill, L.P. Bullock, W.D. Johnson, L.G. Sultatos and E.S. Vesell, 1979, Chloroform toxicity in the mouse: role of genetic factors and steroids, Toxicol. Appl. Pharmacol. 48, 117.
5. Cohen, E.N. and N. Hood, 1969, Application of low-temperature autoradiography to studies of the uptake and metabolism of volatile anesthetics in the mouse. I. Chloroform. Anesthesiology 30, 306.
6. 3 metabolites to microsomal phospholipids, Chem. Biol. Interact, 85, 229.
7. De Curtis, V., S. Gemma, M. Sbraccia, E. Testai and E. Vittozzi, 1994, The contribution of electrophilic and radicalic intermediates to phospholipid adducts formed by halomethanes in vivo, J. Biochem. Toxicol. 9, 305.
8. Folch, J., M. Lees and G.M. Sloane-Stanley, 1957, A simple method for the isolation and purification of total lipids from animal tissues, J. Biol. Chem. 226, 497.
9. Gearhart, J.M., C. Seckel and A. Vinegar, 1993, In vivo metabolism of chloroform in B6C3F1 mice determined by the method uptake:the effects of body temperature on tissue partition coefficients and metabolism, Toxicol. Appl. Pharmacol. 119, 258.
10. Gemma, S., M. Sbraccia, E. Testai and L. Vittozzi, 1994, In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment, Environ. Health Perspect. 102, 45.
11. 3 bioactivation, toxicokinetics, toxicity and induced compensatory cell proliferation in B6C3F1 male mice, Toxicol. Appl. Pharmacol. (in press).
12. Hill, R.N., T.E. Clemens, D.K. Liu, E.S. Vesell and W.D. Johnson, 1975, Genetic control of chloroform toxicity in mice, Science 190, 159.
13. Ji, S., J.J. Lemasters, V. Christenson and R.G. Thurman, 1982, Periportal and pericentral pyridine nucleotide fluorescence from the surface of the perfused liver: evaluation of the hypothesis that chronic treatment with ethanol produces pericentral hypoxia, Proc. Natl. Acad. Sci. USA 79, 5415.
14. Jorgenson, T.A., E.F. Meierhenry, C.J. Rushbrook, R.J. Bull and M. Robinson, 1985, Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice, Fund. Appl. Toxicol. 5, 760.
15. Kessler, M., H. Lang, E. Sinagowitz, R. Rink and J. Hoeper, 1973, Homeostasis of oxygen supply in liver and kidney. Adv. Exp. Med. Biol. 37A, 351.
16. Ilett, K.F., W.D. Reid, I.G. Sipes and G. Krishna, 1973, Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules, Exp. Mol. Pathol. 19, 215.
17. Letteron, P., C. Degott, G. Labbe, D. Larrey, V. Descatoire, M. Tinel and D. Pessayre, 1987, Methoxalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice, Toxicol. Appl. Pharmacol. 91, 266.
18. Mansuy, D., P. Beaune, T.H. Cresteil, M. Lange and J.P. Leroux, 1977, Evidence for phosgene formation during liver microsomal oxidation of chloroform, Biochem. Biophys. Res. Commun. 79, 513.
19. 14C]-trihalomethanes in mice and rats, Bull. Environ. Contam. Toxicol. 37, 752.
20. NCI, 1976, Report on carcinogenesis bioassay of chloroform, Natl. Tech. Inf. Serv. PB-2 64018/AS.64018/AS.
21. Omura, T. and R. Sato, 1964, The carbon monoxide binding pigment of liver microsomes, J. Biol. Chem. 239, 2370.
22. Oyama, V.I. and H. Eagle, 1956, Measurement of cell growth in tissue culture with a phenol reagent (Folin-Ciocalteus), Proc. Soc. Exp. Biol. Med. 91, 305.
23. Palmer, A.K., A.E., Street, F.J.C. Roe, A.N. Worden and N.J. Van Abbe, 1979, Safety evalutation of toothpaste containing chloroform. III. Long term studies in rats, J. Environ. Pathol. Toxicol. 2, 821.
24. Pereira, M.A., 1994, Route of administration determines whether chloroform enhances or inhibits cell proliferation in the liver of B6C3F1 mice, Fund. Appl. Toxicol. 23, 87.
25. Pohl, L.R., B. Bhooshan, N.F. Whittaker and G. Krishna, 1977, Phosgene: a metabolite of chloroform, Biochem. Biophys. Res. Commun. 79, 684.
26. Pohl, L.R., J.W. George, J.L. Martin and G. Krishna, 1979, Deuterium isotope effect in in vivo bioactivation of chloroform to phosgene, Biochem. Pharmacol. 28, 561.
27. Pohl, L.R., J.L. Martin and J.W. George, 1980, Mechanism of metabolic activation of chloroform by rat liver microsomes, Biochem. Pharmacol. 29, 3271.
28. Pohl, L.R., J.W. George and H. Satoh, 1984, Strain and sex differences in chloroform-induced nephrotoxicity. Different rates of metabolism of chloroform to phosgene by the mouse kidney. Drug Metab. Dispos. 12, 304.
29. Roe, F.J.C., A.K. Palmer, A.N. Worden and N.J. Van Abbe, 1979, Safety evalutation of toothpaste containing chloroform. I. Long term studies in mice, J. Environ. Pathol. Toxicol. 2, 799.
30. Rouser, G., A.N. Siakotos and S. Fleischer, 1966, Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots, Lipids 1, 85.
31. Smith, J.H., K. Malta, S.D. Sleight and J.B. Hook, 1983, Mechanism of chloroform nephrotoxicity. I. Time course of chloroform toxicity in male and female mice, Toxicol. Appl. Pharmacol. 70, 467.
32. Smith, J.H., W.R. Hewitt and J.B. Hook, 1985, Role of intrarenal biotransformation in chloroform induced nephrototoxicity in rats, Toxicol. Appl. Pharmacol. 79, 166.
33. Smith, J.H. and J.B. Hook, 1984, Mechanism of chloroform nephrotoxicity III. Renal and hepatic metabolism of chloroform in mice, Toxicol. Appl. Pharmacol. 73, 511.
34. Testai, E. and L. Vittozzi. 1986, Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism, Chem. Biol. Interact. 59, 157.
35. Testai, E., S. Di Marzio and L. Vittozzi, 1990, Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice, Toxicol. Appl. Pharmacol. 104, 496.
36. 3 carcinogenicity, Toxicol. Appl. Pharmacol. 114, 197.
37. 3 metabolism in hepatic microsomes from Osborne Mendel rats, Environ. Health Perspect. 102, 25.
38. Testai, E., S. Di Marzio, A. Di Domenico, A. Piccardi and L. Vittozzi, 1995, An in vitro investigation of the reductive metabolites of chloroform, Arch. Toxicol. 70, 83.
39. Tomasi, A., E. Albano, F. Biasi, T.F. Slater, V. Vannini and M.U. Dianzani, 1985, Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocites and in the rat in vivo as detected by the ESR-spin trapping technique, Chem. Biol. Interact. 55, 303.
40. WHO, 1994, IPCS Environmental Health Criteria 163: Chloroform (WHO, Geneva).